ADAGE CAPITAL PARTNERS GP, L.L.C. - ARCUS BIOSCIENCES INC ownership

ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 151 filers reported holding ARCUS BIOSCIENCES INC in Q4 2020. The put-call ratio across all filers is 0.76 and the average weighting 0.3%.

Quarter-by-quarter ownership
ADAGE CAPITAL PARTNERS GP, L.L.C. ownership history of ARCUS BIOSCIENCES INC
ValueSharesWeighting
Q1 2022$2,367,000
-22.0%
75,0000.0%0.00%
-20.0%
Q4 2021$3,035,000
+16.1%
75,0000.0%0.01%0.0%
Q3 2021$2,615,000
+26.9%
75,0000.0%0.01%
+25.0%
Q2 2021$2,060,000
-70.7%
75,000
-70.0%
0.00%
-71.4%
Q1 2021$7,020,000
+8.2%
250,0000.0%0.01%0.0%
Q4 2020$6,490,000
+51.5%
250,0000.0%0.01%
+27.3%
Q3 2020$4,285,000
-30.7%
250,0000.0%0.01%
-31.2%
Q2 2020$6,185,000250,0000.02%
Other shareholders
ARCUS BIOSCIENCES INC shareholders Q4 2020
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 1,612,077$29,404,28419.15%
Decheng Capital Management III (Cayman), LLC 869,790$15,864,9706.40%
Octagon Capital Advisors LP 2,172,000$39,617,2805.70%
Boxer Capital, LLC 1,432,200$26,1231.28%
PFM Health Sciences, LP 1,559,947$28,453,4331.26%
SECTORAL ASSET MANAGEMENT INC 293,646$5,356,1031.03%
DAFNA Capital Management LLC 175,217$3,195,9580.96%
Ikarian Capital, LLC 230,000$4,195,2000.95%
Tejara Capital Ltd 50,000$912,0000.47%
Capital Impact Advisors, LLC 20,501$373,9380.46%
View complete list of ARCUS BIOSCIENCES INC shareholders